Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes

被引:0
|
作者
Dengpiao Xie
Qiqi Wang
Wei Huang
Liangbin Zhao
机构
[1] Hospital of Chengdu University of Traditional Chinese Medicine,
来源
European Journal of Clinical Pharmacology | 2023年 / 79卷
关键词
Dipeptidyl-peptidase-4 inhibitors; Inflammation; Type 2 diabetes mellitus; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1291 / 1301
页数:10
相关论文
共 50 条
  • [1] Dipeptidyl-peptidase-4 inhibitors have anti-inflammatory effects in patients with type 2 diabetes
    Xie, Dengpiao
    Wang, Qiqi
    Huang, Wei
    Zhao, Liangbin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1291 - 1301
  • [2] Dipeptidyl-peptidase-4 Inhibitors for Treatment of Type 2 Diabetes
    Kripke, Clarissa
    AMERICAN FAMILY PHYSICIAN, 2009, 79 (05) : 372 - 372
  • [3] Licochalcone A Derivatives as Selective Dipeptidyl Peptidase 4 Inhibitors with Anti-Inflammatory Effects
    Li, Ci-Qin
    Shi, Jin-Hui
    Mu, Jie
    Wang, An-Qi
    Zou, Li-Wei
    Ge, Guang-Bo
    JOURNAL OF NATURAL PRODUCTS, 2023, 86 (07): : 1824 - 1831
  • [4] Geospatial distribution of the adoption of dipeptidyl-peptidase-4 inhibitors for type 2 diabetes among Medicare beneficiaries
    Cordes, Jack
    Glynn, Robert J.
    Walker, Alexander M.
    Schneeweiss, Sebastian S.
    SPATIAL AND SPATIO-TEMPORAL EPIDEMIOLOGY, 2025, 52
  • [5] Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes
    Koska, Juraj
    Sands, Michelle
    Burciu, Camelia
    Reaven, Peter
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (03): : 154 - 163
  • [6] A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients
    Satoh-Asahara, Noriko
    Sasaki, Yousuke
    Wada, Hiromichi
    Tochiya, Mayu
    Iguchi, Azusa
    Nakagawachi, Reiko
    Odori, Shinji
    Kono, Shigeo
    Hasegawa, Koji
    Shimatsu, Akira
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (03): : 347 - 351
  • [7] The Effects of Dipeptidyl Peptidase 4 Inhibitors on Renal Function in Patients with Type 2 Diabetes Mellitus
    Hsu, Wan-Chia
    Lin, Chun-Sheng
    Chen, Jung-Fu
    Chang, Chih-Min
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
  • [8] Anti-inflammatory effect of dipeptidyl peptidase 4 inhibitors in the treatment of diabetic cardiovasculopathy
    Zhao, Ruxing
    Hou, Xinguo
    Chen, Li
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [9] Beneficial Impact of Dipeptidyl-peptidase-4 inhibitors on Mortality of Patients With Hospitalized Heart Failure Patients With Diabetes Mellitus
    Sato, Akihiko
    Yoshihisa, Akiomi
    Kanno, Yuki
    Takiguchi, Mai
    Miura, Shunsuke
    Shimizu, Takeshi
    Nakamura, Yuichi
    Yamauchi, Hiroyuki
    Owada, Takashi
    Abe, Satoshi
    Suzuki, Satoshi
    Oikawa, Masayoshi
    Sakamoto, Nobuo
    Yamaki, Takayoshi
    Sugimoto, Koichi
    Kunii, Hiroyuki
    Nakazato, Kazuhiko
    Suzuki, Hitoshi
    Saitoh, Shu-ichi
    Takeishi, Yasuchika
    CIRCULATION, 2015, 132
  • [10] Potential Anti-Atherosclerotic Effects of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus
    Sandeep Dhindsa
    Ishwarlal Jialal
    Current Diabetes Reports, 2014, 14